Lista de obras -

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

artículo científico publicado en 2019

A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer.

artículo científico publicado en 2010

Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study

article

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France

artículo científico publicado en 2015

Cancer de la prostate

article

Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

artículo científico publicado en 2009

Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature

artículo científico publicado en 2016

Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study

artículo científico publicado en 2013

Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trial

artículo científico publicado en 2013

Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry ⬇️

artículo científico publicado el 18 de febrero de 2011

Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data

artículo científico publicado en 2010

DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma.

artículo científico publicado en 2006

Detection and characterization of putative metastatic precursor cells in cancer patients

artículo científico publicado en 2007

Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients

artículo científico publicado en 2005

Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey

artículo científico publicado en 2015

Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome

artículo científico publicado en 2005

Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database

artículo científico publicado en 2020

Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer

artículo científico publicado en 2013

Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP study.

artículo científico publicado en 2018

Follow-up of prostate cancer. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie

scientific article published on 01 September 2005

Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot study.

artículo científico publicado en 2003

Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations

article

High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure

artículo científico publicado en 2009

High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology

scientific article published on 04 March 2008

Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: potential and technical improvements.

artículo científico publicado en 2008

La prostate : Identification des attentes du médecin généraliste. Une enquête qualitative. Association Française d’Urologie (AFU) - IPSOS

artículo científico publicado en 2007

Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer

artículo científico publicado en 2015

Methodological considerations in cost of prostate cancer studies: a systematic review

artículo científico publicado en 2008

Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages.

artículo científico publicado en 2013

Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients

artículo científico publicado en 2010

Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study.

artículo científico publicado en 2017

Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy

artículo científico publicado en 2014

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

artículo científico publicado en 2009

Prostate-cancer mortality at 11 years of follow-up

artículo científico publicado en 2012

Prostatitis, other genitourinary infections and prostate cancer risk: Influence of non-steroidal anti-inflammatory drugs? Results from the EPICAP study

artículo científico publicado en 2018

Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification

artículo científico publicado en 2011

Radium 223 dichloride for prostate cancer treatment

artículo científico publicado en 2017

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

artículo científico publicado en 2014

Screening and prostate-cancer mortality in a randomized European study

artículo científico publicado en 2009

Seasonality of serum prostate-specific antigen levels: a population-based study

artículo científico publicado en 2006

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.

artículo científico publicado en 2014

Stage pT0 after radical prostatectomy with previous positive biopsy sets: a multicenter study

artículo científico publicado en 2010

Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma: results of a French regional experience in Languedoc.

artículo científico publicado en 2006

Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate Cancer

artículo científico publicado en 2016

Technology insight: High-intensity focused ultrasound for urologic cancers

artículo científico publicado en 2005

The level of evidence for the use of biomarkers in the early detection of prostate cancer

artículo científico publicado en 2016

Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer Center

artículo científico publicado en 2012

Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer

artículo científico publicado en 2005

Urinary incontinence and sexual dysfunction after treatment of localized prostate cancer: Results from a population aged less than 65years old

artículo científico publicado en 2016

[Biopsy technique and biopsy schemes for a first series of prostatic biopsies]

artículo científico publicado en 2004

[Circulating tumor cells and advanced prostate cancer].

artículo científico publicado en 2012

[Organization of care in oncologic urology in the framework of cancer care]

artículo científico publicado en 2007

[PSA doubling time and method of calculation]

artículo científico publicado en 2005

[Place of contrast imaging in prostate cancer detection]

artículo científico publicado en 2006

[Presentation of a urologic cancer file in team work]

artículo científico publicado en 2004

[Prostate cancer screening]

artículo científico publicado en 2003

[Prostatic cancer].

artículo científico publicado en 2004

[Standardized calculation in the pathology of urologic cancers]

artículo científico publicado en 2007

[The uropathological standardized reports]

scientific article published on 01 October 2008

[Urologic cancer at the Hérault department: 14 years of continuous registration]

scientific article published on 01 June 2003

[What is the objective of second-line chemotherapy after failure of first-line chemotherapy in hormone-resistant metastatic prostate?]

artículo científico publicado en 2006

Lista de obras de

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer.

Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France

Cancer de la prostate

Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature

Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study

Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trial

Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry ⬇️

Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data

DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma.

Detection and characterization of putative metastatic precursor cells in cancer patients

Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients

Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey

Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome

Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database

Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer

Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP study.

Follow-up of prostate cancer. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie

Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot study.

Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations

High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure

High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology

Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: potential and technical improvements.

La prostate : Identification des attentes du médecin généraliste. Une enquête qualitative. Association Française d’Urologie (AFU) - IPSOS

Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer

Methodological considerations in cost of prostate cancer studies: a systematic review

Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages.

Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients

Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study.

Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

Prostate-cancer mortality at 11 years of follow-up

Prostatitis, other genitourinary infections and prostate cancer risk: Influence of non-steroidal anti-inflammatory drugs? Results from the EPICAP study

Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification

Radium 223 dichloride for prostate cancer treatment

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Screening and prostate-cancer mortality in a randomized European study

Seasonality of serum prostate-specific antigen levels: a population-based study

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.

Stage pT0 after radical prostatectomy with previous positive biopsy sets: a multicenter study

Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma: results of a French regional experience in Languedoc.

Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate Cancer

Technology insight: High-intensity focused ultrasound for urologic cancers

The level of evidence for the use of biomarkers in the early detection of prostate cancer

Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer Center

Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer

Urinary incontinence and sexual dysfunction after treatment of localized prostate cancer: Results from a population aged less than 65years old

[Biopsy technique and biopsy schemes for a first series of prostatic biopsies]

[Circulating tumor cells and advanced prostate cancer].

[Organization of care in oncologic urology in the framework of cancer care]

[PSA doubling time and method of calculation]

[Place of contrast imaging in prostate cancer detection]

[Presentation of a urologic cancer file in team work]

[Prostate cancer screening]

[Prostatic cancer].

[Standardized calculation in the pathology of urologic cancers]

[The uropathological standardized reports]

[Urologic cancer at the Hérault department: 14 years of continuous registration]

[What is the objective of second-line chemotherapy after failure of first-line chemotherapy in hormone-resistant metastatic prostate?]